Asia Pacific Carrier Testing Services Market Size and Forecast (2021 - 2031)
The Asia Pacific Carrier Testing Services Market is projected to grow significantly, reaching an estimated US$ 460.6 million by 2031, up from US$ 154.0 million in 2024. This growth reflects a robust compound annual growth rate (CAGR) of 17.3% from 2025 to 2031.
Executive Summary and Market Analysis
The carrier testing services market in the Asia Pacific region is divided into several key countries, including China, Japan, India, South Korea, Australia, and other Pacific nations. Notably, countries like China, India, and Japan are making substantial investments in reproductive health and genomics research, fostering a favorable environment for companies specializing in carrier screening. The diverse and large populations in these countries exhibit a strong preference for multi-gene carrier panels, which cater to varying genetic risks across different demographics.
As laboratory capabilities improve and sequencing costs decline, both public health initiatives and private fertility clinics are increasingly integrating carrier screening into prenatal care. Local laboratories are enhancing their service offerings by adopting advanced techniques such as Next-Generation Sequencing (NGS) and are open to collaborating with global genomics firms to develop region-specific panels that address local genetic variants.
The Asia Pacific market is particularly attractive due to its large population, rising middle-class incomes, and growing acceptance of genetic medicine. However, companies looking to enter this market must navigate challenges such as regulatory differences, infrastructure disparities between urban and rural areas, and varying reimbursement policies. By focusing on education, forming partnerships, and providing localized solutions, businesses can effectively expand their reach in the carrier testing services sector.
Strategic Insights
Market Segmentation Analysis
The Asia Pacific Carrier Testing Services Market is categorized based on several criteria:
Carrier testing is becoming an integral part of precision medicine, allowing for proactive reproductive health management by assessing the risk of passing on inherited disorders. The completion of the Human Genome Project and the decreasing costs of sequencing have made carrier testing services both technically feasible and commercially viable. The establishment of national genomic policies is also contributing to the integration of carrier testing into standard healthcare practices.
Medical diagnostics companies are expanding their carrier screening offerings. For instance, Illumina has launched its DRAGEN v4.3 software, which utilizes artificial intelligence to enhance variant calling and support expanded carrier panels. As genomic research advances, carrier testing is proving valuable for reproductive planning, population health initiatives, and preventive healthcare. While traditionally associated with identifying carriers of genetic disorders like cystic fibrosis and spinal muscular atrophy, this technology also aids couples in family planning by providing data-driven insights that facilitate informed decision-making. Early interventions enabled by carrier testing can significantly reduce long-term healthcare costs.
Country Insights
The Asia Pacific Carrier Testing Services Market is further segmented by country, including China, Japan, India, Australia, South Korea, and the Rest of APAC. Japan held the largest market share in 2024. In Japan, clinical and private hospitals are increasingly offering Expanded Carrier Panels (ECP) using NGS for autosomal recessive and X-linked conditions, indicating a growing acceptance of these methods among healthcare providers. However, Japan's aging population and lower birth rates result in fewer couples seeking preconception and prenatal screenings compared to younger Southeast Asian nations. Nonetheless, there is a rising trend in preventive reproductive health, particularly in fertility clinics catering to couples considering IVF or donor-assisted reproduction.
Japan boasts advanced sequencing and diagnostic infrastructure, supported by leading academic genomics centers. Although comprehensive national carrier screening programs are lacking, private companies are stepping in to provide screening services alongside genetic counseling and NGS diagnostics. Japan represents a premium niche market where companies can focus on developing high-quality, clinically validated assays and foster collaborations with fertility and diagnostic centers. Future growth in this market will depend on regulatory compliance, collaboration, and educating younger reproductive-aged couples about the benefits of carrier screening.
Company Profiles
Key players in the Asia Pacific Carrier Testing Services Market include F. Hoffmann-La Roche Ltd, Quest Diagnostics Inc, Eurofins Scientific SE, Myriad Genetics Inc, Laboratory Corp of America Holdings, MedGenome Inc, Gene By Gene Ltd, Thermo Fisher Scientific Inc., Fulgent Genetics, Inc, and Illumina, Inc. These companies are employing various strategies such as market expansion, product innovation, and mergers and acquisitions to enhance their offerings and increase their market share.
Executive Summary and Market Analysis
The carrier testing services market in the Asia Pacific region is divided into several key countries, including China, Japan, India, South Korea, Australia, and other Pacific nations. Notably, countries like China, India, and Japan are making substantial investments in reproductive health and genomics research, fostering a favorable environment for companies specializing in carrier screening. The diverse and large populations in these countries exhibit a strong preference for multi-gene carrier panels, which cater to varying genetic risks across different demographics.
As laboratory capabilities improve and sequencing costs decline, both public health initiatives and private fertility clinics are increasingly integrating carrier screening into prenatal care. Local laboratories are enhancing their service offerings by adopting advanced techniques such as Next-Generation Sequencing (NGS) and are open to collaborating with global genomics firms to develop region-specific panels that address local genetic variants.
The Asia Pacific market is particularly attractive due to its large population, rising middle-class incomes, and growing acceptance of genetic medicine. However, companies looking to enter this market must navigate challenges such as regulatory differences, infrastructure disparities between urban and rural areas, and varying reimbursement policies. By focusing on education, forming partnerships, and providing localized solutions, businesses can effectively expand their reach in the carrier testing services sector.
Strategic Insights
Market Segmentation Analysis
The Asia Pacific Carrier Testing Services Market is categorized based on several criteria:
- By Type: The market is divided into Expanded Carrier Screening and Targeted Disease Carrier Screening, with the Expanded Carrier Screening segment leading the market in 2024.
- By Medical Conditions: The market is segmented into Pulmonary Conditions, Hematological Conditions, Neurological Conditions, and Other Medical Conditions, where Pulmonary Conditions held the largest share in 2024.
- By End User: The market is classified into Hospital-Based Laboratories, Diagnostic Laboratories, and Other End Users, with Hospital-Based Laboratories dominating in 2024.
Carrier testing is becoming an integral part of precision medicine, allowing for proactive reproductive health management by assessing the risk of passing on inherited disorders. The completion of the Human Genome Project and the decreasing costs of sequencing have made carrier testing services both technically feasible and commercially viable. The establishment of national genomic policies is also contributing to the integration of carrier testing into standard healthcare practices.
Medical diagnostics companies are expanding their carrier screening offerings. For instance, Illumina has launched its DRAGEN v4.3 software, which utilizes artificial intelligence to enhance variant calling and support expanded carrier panels. As genomic research advances, carrier testing is proving valuable for reproductive planning, population health initiatives, and preventive healthcare. While traditionally associated with identifying carriers of genetic disorders like cystic fibrosis and spinal muscular atrophy, this technology also aids couples in family planning by providing data-driven insights that facilitate informed decision-making. Early interventions enabled by carrier testing can significantly reduce long-term healthcare costs.
Country Insights
The Asia Pacific Carrier Testing Services Market is further segmented by country, including China, Japan, India, Australia, South Korea, and the Rest of APAC. Japan held the largest market share in 2024. In Japan, clinical and private hospitals are increasingly offering Expanded Carrier Panels (ECP) using NGS for autosomal recessive and X-linked conditions, indicating a growing acceptance of these methods among healthcare providers. However, Japan's aging population and lower birth rates result in fewer couples seeking preconception and prenatal screenings compared to younger Southeast Asian nations. Nonetheless, there is a rising trend in preventive reproductive health, particularly in fertility clinics catering to couples considering IVF or donor-assisted reproduction.
Japan boasts advanced sequencing and diagnostic infrastructure, supported by leading academic genomics centers. Although comprehensive national carrier screening programs are lacking, private companies are stepping in to provide screening services alongside genetic counseling and NGS diagnostics. Japan represents a premium niche market where companies can focus on developing high-quality, clinically validated assays and foster collaborations with fertility and diagnostic centers. Future growth in this market will depend on regulatory compliance, collaboration, and educating younger reproductive-aged couples about the benefits of carrier screening.
Company Profiles
Key players in the Asia Pacific Carrier Testing Services Market include F. Hoffmann-La Roche Ltd, Quest Diagnostics Inc, Eurofins Scientific SE, Myriad Genetics Inc, Laboratory Corp of America Holdings, MedGenome Inc, Gene By Gene Ltd, Thermo Fisher Scientific Inc., Fulgent Genetics, Inc, and Illumina, Inc. These companies are employing various strategies such as market expansion, product innovation, and mergers and acquisitions to enhance their offerings and increase their market share.
1. INTRODUCTION
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. CARRIER TESTING SERVICES MARKET LANDSCAPE
4.1 Market Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
4.3.1 List of Vendors in the Value Chain
5. ASIA PACIFIC CARRIER TESTING SERVICES MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. CARRIER TESTING SERVICES MARKET - ASIA PACIFIC MARKET ANALYSIS
6.1 Asia Pacific Carrier Testing Services Market Revenue (US$ Million), 2024 - 2031
6.2 Asia Pacific Carrier Testing Services Market Forecast and Analysis
7. ASIA PACIFIC CARRIER TESTING SERVICES MARKET REVENUE ANALYSIS - BY TYPE
7.1 Expanded Carrier Screening
7.1.1 Overview
7.1.2 Expanded Carrier Screening: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Targeted Disease Carrier Screening
7.2.1 Overview
7.2.2 Targeted Disease Carrier Screening: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. ASIA PACIFIC CARRIER TESTING SERVICES MARKET REVENUE ANALYSIS - BY MEDICAL CONDITIONS
8.1 Pulmonary Conditions
8.1.1 Overview
8.1.2 Pulmonary Conditions: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Hematological Conditions
8.2.1 Overview
8.2.2 Hematological Conditions: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Neurological Conditions
8.3.1 Overview
8.3.2 Neurological Conditions: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.4 Other Medical Conditions
8.4.1 Overview
8.4.2 Other Medical Conditions: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. ASIA PACIFIC CARRIER TESTING SERVICES MARKET REVENUE ANALYSIS - BY END USER
9.1 Hospital-Based Laboratories
9.1.1 Overview
9.1.2 Hospital-Based Laboratories: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Diagnostic Laboratories
9.2.1 Overview
9.2.2 Diagnostic Laboratories: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Other End Users
9.3.1 Overview
9.3.2 Other End Users: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. ASIA PACIFIC CARRIER TESTING SERVICES MARKET - COUNTRY ANALYSIS
10.1 Asia Pacific
10.1.1 Asia Pacific Carrier Testing Services Market Revenue and Forecast and Analysis - by Country
10.1.1.1 Asia Pacific Carrier Testing Services Market Revenue and Forecast and Analysis - by Country
10.1.2.2 China: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.1.2.2.1 China: Asia Pacific Carrier Testing Services Market Share - by Type
10.1.2.2.2 China: Asia Pacific Carrier Testing Services Market Share - by Medical Conditions
10.1.2.2.3 China: Asia Pacific Carrier Testing Services Market Share - by End User
10.2.3.3 Japan: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2.3.3.1 Japan: Asia Pacific Carrier Testing Services Market Share - by Type
10.2.3.3.2 Japan: Asia Pacific Carrier Testing Services Market Share - by Medical Conditions
10.2.3.3.3 Japan: Asia Pacific Carrier Testing Services Market Share - by End User
10.3.4.4 India: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3.4.4.1 India: Asia Pacific Carrier Testing Services Market Share - by Type
10.3.4.4.2 India: Asia Pacific Carrier Testing Services Market Share - by Medical Conditions
10.3.4.4.3 India: Asia Pacific Carrier Testing Services Market Share - by End User
10.4.5.5 Australia: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.4.5.5.1 Australia: Asia Pacific Carrier Testing Services Market Share - by Type
10.4.5.5.2 Australia: Asia Pacific Carrier Testing Services Market Share - by Medical Conditions
10.4.5.5.3 Australia: Asia Pacific Carrier Testing Services Market Share - by End User
10.5.6.6 South Korea: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.5.6.6.1 South Korea: Asia Pacific Carrier Testing Services Market Share - by Type
10.5.6.6.2 South Korea: Asia Pacific Carrier Testing Services Market Share - by Medical Conditions
10.5.6.6.3 South Korea: Asia Pacific Carrier Testing Services Market Share - by End User
10.6.7.7 Rest of APAC: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.6.7.7.1 Rest of APAC: Asia Pacific Carrier Testing Services Market Share - by Type
10.6.7.7.2 Rest of APAC: Asia Pacific Carrier Testing Services Market Share - by Medical Conditions
10.6.7.7.3 Rest of APAC: Asia Pacific Carrier Testing Services Market Share - by End User
11 COMPETITIVE LANDSCAPE
11.1 Heat Map Analysis by Key Players
11.2 Company Positioning & Concentration
12 INDUSTRY LANDSCAPE
12.1 Overview
12.2 New Product Development
12.3 Merger and Acquisition
12.4 Other Strategic Developments
13 COMPANY PROFILES
13.1 F. Hoffmann-La Roche Ltd
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Quest Diagnostics Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Eurofins Scientific SE
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Myriad Genetics Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Laboratory Corp of America Holdings
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 MedGenome Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Gene By Gene Ltd
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Thermo Fisher Scientific Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Fulgent Genetics, Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Illumina, Inc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. APPENDIX
14.1 About The Insight Partners
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. CARRIER TESTING SERVICES MARKET LANDSCAPE
4.1 Market Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
4.3.1 List of Vendors in the Value Chain
5. ASIA PACIFIC CARRIER TESTING SERVICES MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. CARRIER TESTING SERVICES MARKET - ASIA PACIFIC MARKET ANALYSIS
6.1 Asia Pacific Carrier Testing Services Market Revenue (US$ Million), 2024 - 2031
6.2 Asia Pacific Carrier Testing Services Market Forecast and Analysis
7. ASIA PACIFIC CARRIER TESTING SERVICES MARKET REVENUE ANALYSIS - BY TYPE
7.1 Expanded Carrier Screening
7.1.1 Overview
7.1.2 Expanded Carrier Screening: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Targeted Disease Carrier Screening
7.2.1 Overview
7.2.2 Targeted Disease Carrier Screening: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. ASIA PACIFIC CARRIER TESTING SERVICES MARKET REVENUE ANALYSIS - BY MEDICAL CONDITIONS
8.1 Pulmonary Conditions
8.1.1 Overview
8.1.2 Pulmonary Conditions: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Hematological Conditions
8.2.1 Overview
8.2.2 Hematological Conditions: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Neurological Conditions
8.3.1 Overview
8.3.2 Neurological Conditions: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.4 Other Medical Conditions
8.4.1 Overview
8.4.2 Other Medical Conditions: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. ASIA PACIFIC CARRIER TESTING SERVICES MARKET REVENUE ANALYSIS - BY END USER
9.1 Hospital-Based Laboratories
9.1.1 Overview
9.1.2 Hospital-Based Laboratories: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Diagnostic Laboratories
9.2.1 Overview
9.2.2 Diagnostic Laboratories: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Other End Users
9.3.1 Overview
9.3.2 Other End Users: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. ASIA PACIFIC CARRIER TESTING SERVICES MARKET - COUNTRY ANALYSIS
10.1 Asia Pacific
10.1.1 Asia Pacific Carrier Testing Services Market Revenue and Forecast and Analysis - by Country
10.1.1.1 Asia Pacific Carrier Testing Services Market Revenue and Forecast and Analysis - by Country
10.1.2.2 China: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.1.2.2.1 China: Asia Pacific Carrier Testing Services Market Share - by Type
10.1.2.2.2 China: Asia Pacific Carrier Testing Services Market Share - by Medical Conditions
10.1.2.2.3 China: Asia Pacific Carrier Testing Services Market Share - by End User
10.2.3.3 Japan: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2.3.3.1 Japan: Asia Pacific Carrier Testing Services Market Share - by Type
10.2.3.3.2 Japan: Asia Pacific Carrier Testing Services Market Share - by Medical Conditions
10.2.3.3.3 Japan: Asia Pacific Carrier Testing Services Market Share - by End User
10.3.4.4 India: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3.4.4.1 India: Asia Pacific Carrier Testing Services Market Share - by Type
10.3.4.4.2 India: Asia Pacific Carrier Testing Services Market Share - by Medical Conditions
10.3.4.4.3 India: Asia Pacific Carrier Testing Services Market Share - by End User
10.4.5.5 Australia: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.4.5.5.1 Australia: Asia Pacific Carrier Testing Services Market Share - by Type
10.4.5.5.2 Australia: Asia Pacific Carrier Testing Services Market Share - by Medical Conditions
10.4.5.5.3 Australia: Asia Pacific Carrier Testing Services Market Share - by End User
10.5.6.6 South Korea: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.5.6.6.1 South Korea: Asia Pacific Carrier Testing Services Market Share - by Type
10.5.6.6.2 South Korea: Asia Pacific Carrier Testing Services Market Share - by Medical Conditions
10.5.6.6.3 South Korea: Asia Pacific Carrier Testing Services Market Share - by End User
10.6.7.7 Rest of APAC: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.6.7.7.1 Rest of APAC: Asia Pacific Carrier Testing Services Market Share - by Type
10.6.7.7.2 Rest of APAC: Asia Pacific Carrier Testing Services Market Share - by Medical Conditions
10.6.7.7.3 Rest of APAC: Asia Pacific Carrier Testing Services Market Share - by End User
11 COMPETITIVE LANDSCAPE
11.1 Heat Map Analysis by Key Players
11.2 Company Positioning & Concentration
12 INDUSTRY LANDSCAPE
12.1 Overview
12.2 New Product Development
12.3 Merger and Acquisition
12.4 Other Strategic Developments
13 COMPANY PROFILES
13.1 F. Hoffmann-La Roche Ltd
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Quest Diagnostics Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Eurofins Scientific SE
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Myriad Genetics Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Laboratory Corp of America Holdings
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 MedGenome Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Gene By Gene Ltd
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Thermo Fisher Scientific Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Fulgent Genetics, Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Illumina, Inc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. APPENDIX
14.1 About The Insight Partners
LIST OF TABLES
Table 1. Asia Pacific Carrier Testing Services Market Segmentation
Table 2. List of Vendors
Table 3. Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 5. Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Medical Conditions
Table 6. Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 7. Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 8. China: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 9. China: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Medical Conditions
Table 10. China: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 11. Japan: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 12. Japan: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Medical Conditions
Table 13. Japan: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 14. India: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 15. India: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Medical Conditions
Table 16. India: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 17. Australia: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 18. Australia: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Medical Conditions
Table 19. Australia: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 20. South Korea: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 21. South Korea: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Medical Conditions
Table 22. South Korea: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 23. Rest of APAC: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 24. Rest of APAC: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Medical Conditions
Table 25. Rest of APAC: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 26. Heat Map Analysis by Key Players
Table 1. Asia Pacific Carrier Testing Services Market Segmentation
Table 2. List of Vendors
Table 3. Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 5. Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Medical Conditions
Table 6. Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 7. Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 8. China: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 9. China: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Medical Conditions
Table 10. China: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 11. Japan: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 12. Japan: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Medical Conditions
Table 13. Japan: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 14. India: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 15. India: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Medical Conditions
Table 16. India: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 17. Australia: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 18. Australia: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Medical Conditions
Table 19. Australia: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 20. South Korea: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 21. South Korea: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Medical Conditions
Table 22. South Korea: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 23. Rest of APAC: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 24. Rest of APAC: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Medical Conditions
Table 25. Rest of APAC: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 26. Heat Map Analysis by Key Players
LIST OF FIGURES
Figure 1. Asia Pacific Carrier Testing Services Market Segmentation - Country
Figure 2. PEST Analysis
Figure 3. Ecosystem: Carrier Testing Services Market
Figure 4. Asia Pacific Carrier Testing Services Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Asia Pacific Carrier Testing Services Market Revenue (US$ Million), 2024 - 2031
Figure 7. Asia Pacific Carrier Testing Services Market Share (%) - by Type, 2024 and 2031
Figure 8. Expanded Carrier Screening: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Targeted Disease Carrier Screening: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Asia Pacific Carrier Testing Services Market Share (%) - by Medical Conditions, 2024 and 2031
Figure 11. Pulmonary Conditions: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Hematological Conditions: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Neurological Conditions: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Other Medical Conditions: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. Asia Pacific Carrier Testing Services Market Share (%) - by End User, 2024 and 2031
Figure 16. Hospital-Based Laboratories: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Diagnostic Laboratories: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Other End Users: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Asia Pacific Carrier Testing Services Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 20. China: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Japan: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. India: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. Australia: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. South Korea: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Rest of APAC: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 26. Company Positioning & Concentration
Figure 1. Asia Pacific Carrier Testing Services Market Segmentation - Country
Figure 2. PEST Analysis
Figure 3. Ecosystem: Carrier Testing Services Market
Figure 4. Asia Pacific Carrier Testing Services Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Asia Pacific Carrier Testing Services Market Revenue (US$ Million), 2024 - 2031
Figure 7. Asia Pacific Carrier Testing Services Market Share (%) - by Type, 2024 and 2031
Figure 8. Expanded Carrier Screening: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Targeted Disease Carrier Screening: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Asia Pacific Carrier Testing Services Market Share (%) - by Medical Conditions, 2024 and 2031
Figure 11. Pulmonary Conditions: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Hematological Conditions: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Neurological Conditions: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Other Medical Conditions: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. Asia Pacific Carrier Testing Services Market Share (%) - by End User, 2024 and 2031
Figure 16. Hospital-Based Laboratories: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Diagnostic Laboratories: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Other End Users: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Asia Pacific Carrier Testing Services Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 20. China: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Japan: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. India: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. Australia: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. South Korea: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Rest of APAC: Asia Pacific Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 26. Company Positioning & Concentration
